Roxanna Valayathum

Sector Head, Director

Roxanna Valayathum is a Director in our Corporate & Commercial practice, and is Sector Head of the  Healthcare & Pharmaceuticals sector. Roxanna specialises in mergers and acquisitions across various sectors and jurisdictions, the structuring and restructuring of businesses, general corporate and commercial law advice, and agreements as well as cross border due diligence investigations.

 

Roxanna Valayathum

About Roxanna

Roxanna began her career as a Candidate Attorney at Tabacks in 2010 and was retained as an Associate in 2012. Roxanna joined Cliffe Dekker Hofmeyr as a Senior Associate in 2015 and was appointed as a Director in 2018.



Areas of expertise

Experience

  • Advised Sanofi-Aventis South Africa Proprietary Limited in the sale by Sanofi-Aventis South Africa Proprietary Limited of its entire shareholding in Opella Healthcare South Proprietary Limited, which housed its South Africa based consumer healthcare unit and CHOICE range of products, to CFAO Société Anonyme.

  • Advised and provided legal support to the Industrial Development Corporation in implementing, as part of the Presidential Employment Stimulus, its award-winning Social Employment Fund project that created over 100,000 job opportunities as part of its mandate to advance sustainable job creation throughout communities in South Africa.

  • Advised an ICT company in the acquisition of the entire issued share capital of a cloud solutions and consulting services company.

  • Advised a petroleum company in relation to its retail operations in South Africa.

  • Advised Zambezi Platinum (RF) Limited on the acceleration of the maturity of the empowerment transaction concluded between Northam Platinum Limited and Zambezi Platinum (RF) Limited in May 2015.

  • Advised Capitalworks, a private equity fund, in relation to its take private offer in respect of the Peregrine Group, a financial services group listed on the JSE and the A2X.

  • Assisted with the spin off by Pfizer Incorporated of its Upjohn Business into a separate subsidiary for the purposes of the merger thereof with Mylan N.V. to form Viatris Incorporated.

  • Advised South African corporate law aspects of the restructure of a multinational French pharmaceutical company.

  • Advised ArcelorMittal South Africa Limited in its acquisition of the Highveld Structural Mill from Evraz Highveld Steel and Vanadium (in business rescue).

  • Advised JCDecaux on a number of matters, including; the restructure of its operations in Nigeria; and the acquisition by JCDecaux of shares in an advertising company operating in South Africa.

  • Advised Caixa Geral de Depósitos, S.A. in the disposal of its entire shareholding in Mercantile Bank Holdings Limited to Capitec Bank Limited and in the establishment thereafter of Caixa Geral de Depósitos, S.A's branch office in South Africa.

  • Advised Sage Pay Proprietary Limited in the divestment of a business division.

  • Advised a multinational cosmetics company in establishing operations in Swaziland, Lesotho, Botswana and Kenya.

  • Advised MultiChoice Africa Limited, in the restructure of its operations across 42 jurisdictions in Africa.

  • Advised FAAC S.p.A, the sole shareholder of Zeag SA Proprietary Limited, in the acquisition by Zeag SA of the entire issued share capital of Centurion Systems Proprietary Limited.

  • Advised Safika Cement Holdings (Pty) Ltd in respect of the acquisition by PPC Ltd of a 69.3% interest in Safika Cement Holdings (Pty) Ltd.

  • Advised Maragon Private Schools Ruimsig Proprietary Limited in respect of the acquisition by RMB Corvest of a 49.9% interest in Maragon; and the acquisition by Maragon of the Doxa Deo and Charterhouse schools.

  • Advised Capitalworks Investment Partners (Pty) Ltd in respect of its acquisition of the Rosond group of companies.

Recognition

  • The Legal 500 EMEA 2024 - 2025 mentioned Roxanna for Commercial, Corporate/M&A.

Credentials

Education

  • Registered with the Legal Practice Council
  • LLB (cum laude), University of the Witwatersrand
  • Competition Law Certificate, University of the Witwatersrand
  • LLM (Commercial Law), University of Johannesburg
  • Year admitted as an attorney: 2012

LANGUAGES

  • English

News

Updates on CIPC deregistration due to non-compliance
Corporate & Commercial Law

Updates on CIPC deregistration due to non-compliance

In accordance with Customer Notice 9 of 2005 issued by the Companies and Intellectual Property Commission (CIPC), the CIPC is continuing the ongoing automated process of referring...

Time-travelling contracts: Pre-incorporation contracts under the Companies Act
Corporate & Commercial Law

Time-travelling contracts: Pre-incorporation contracts under the Companies Act

Starting a business is challenging enough – ensuring it runs smoothly and is able to successfully operate from day one should not be one of those challenges.

Seminar Recording | Inaugural Company Law Developments Conference
Corporate & Commercial Law

Seminar Recording | Inaugural Company Law Developments Conference

The Cutting Edge on M&A and Takeover law – major developments, big ideas and unresolved issues.

Monetary claims in events of contractual breach

Monetary claims in events of contractual breach

At the outset of a commercial transaction, contracting parties typically do not conceive of the consequences that may arise should a breach occur, and thus do not always fully consider...

The goals, timing and criticisms of the NHI Act
Healthcare & Pharmaceuticals

The goals, timing and criticisms of the NHI Act

On 15 May 2024, President Cyril Ramaphosa signed the National Health Insurance Bill into law. The National Health Insurance Act 20 of 2023 (NHI Act) marks a pivotal moment in South...

Know your limitations: Lessons from English case law on limitations of liability
Corporate & Commercial Law

Know your limitations: Lessons from English case law on limitations of liability

Managing risk and allocating liability forms the focal (and sticking) point of many agreements, whether transactional (e.g. a sale) or relationship-based (e.g. a services agreement)....

The rise of ESG in mergers and acquisitions
Corporate & Commercial Law

The rise of ESG in mergers and acquisitions

The rise of ESG in M&A represents a significant shift in the corporate world.

Shareholders take heed: The removal of a director where a shareholder has requestioned a meeting
Corporate & Commercial Law

Shareholders take heed: The removal of a director where a shareholder has requestioned a meeting

In instances where a director does not act in the company’s best interests, the danger of causing reputational harm arises. It is commonplace for the solution to lie in the removal...

Social and Ethics Committees: A reflection on the treatment of exemption applications in the Companies Tribunal
Corporate & Commercial Law

Social and Ethics Committees: A reflection on the treatment of exemption applications in the Companies Tribunal

The Companies Tribunal Annual Report 2020 – 2021 indicates that there has been a gradual increase in applications for exemptions from establishing Social and Ethics Committees (SECs)...

The role of mergers and acquisitions in the pharmaceutical industry
Corporate & Commercial Law

The role of mergers and acquisitions in the pharmaceutical industry

Corporate & Commercial Director Roxanna Valayathum and Candidate Attorney Carmin Jansen van Vuuren, featured in a DealMakers Magazine article titled "The role of mergers and acquisitions...

The role of mergers and acquisitions in the pharmaceutical industry
Healthcare & Pharmaceuticals

The role of mergers and acquisitions in the pharmaceutical industry

The pharmaceutical industry is dynamic – not just in current times but also historically. It is not surprising that the industry is one of the frontrunners in the market space when...

Is the SPAC back?
Corporate & Commercial Law

Is the SPAC back?

The use of SPACs, or special purpose acquisition companies, seems to be back. SPACs are shell companies with no existing business operations, that are established as an investment...

Reconsidering ordinary course of business covenants in M&A agreements during a pandemic

Reconsidering ordinary course of business covenants in M&A agreements during a pandemic

In concluding M&A transactions in such volatile times it is more imperative than ever that purchasers commencing new M&A transactions (which cater for an interim period between signing...

Disruptive technology and its impact on the M&A landscape
Corporate & Commercial Law

Disruptive technology and its impact on the M&A landscape

If a decade ago someone had told you that you’d be comfortable sharing your location with a stranger, hop into that stranger’s car and trust them to take you where you wanted to go, you would’ve...

Updates on CIPC deregistration due to non-compliance
Corporate & Commercial Law

Updates on CIPC deregistration due to non-compliance

In accordance with Customer Notice 9 of 2005 issued by the Companies and Intellectual Property Commission (CIPC), the CIPC is continuing the ongoing automated process of referring...

Time-travelling contracts: Pre-incorporation contracts under the Companies Act
Corporate & Commercial Law

Time-travelling contracts: Pre-incorporation contracts under the Companies Act

Starting a business is challenging enough – ensuring it runs smoothly and is able to successfully operate from day one should not be one of those challenges.

Monetary claims in events of contractual breach

Monetary claims in events of contractual breach

At the outset of a commercial transaction, contracting parties typically do not conceive of the consequences that may arise should a breach occur, and thus do not always fully consider...

The goals, timing and criticisms of the NHI Act
Healthcare & Pharmaceuticals

The goals, timing and criticisms of the NHI Act

On 15 May 2024, President Cyril Ramaphosa signed the National Health Insurance Bill into law. The National Health Insurance Act 20 of 2023 (NHI Act) marks a pivotal moment in South...

Know your limitations: Lessons from English case law on limitations of liability
Corporate & Commercial Law

Know your limitations: Lessons from English case law on limitations of liability

Managing risk and allocating liability forms the focal (and sticking) point of many agreements, whether transactional (e.g. a sale) or relationship-based (e.g. a services agreement)....

Shareholders take heed: The removal of a director where a shareholder has requestioned a meeting
Corporate & Commercial Law

Shareholders take heed: The removal of a director where a shareholder has requestioned a meeting

In instances where a director does not act in the company’s best interests, the danger of causing reputational harm arises. It is commonplace for the solution to lie in the removal...

Social and Ethics Committees: A reflection on the treatment of exemption applications in the Companies Tribunal
Corporate & Commercial Law

Social and Ethics Committees: A reflection on the treatment of exemption applications in the Companies Tribunal

The Companies Tribunal Annual Report 2020 – 2021 indicates that there has been a gradual increase in applications for exemptions from establishing Social and Ethics Committees (SECs)...

The role of mergers and acquisitions in the pharmaceutical industry
Corporate & Commercial Law

The role of mergers and acquisitions in the pharmaceutical industry

Corporate & Commercial Director Roxanna Valayathum and Candidate Attorney Carmin Jansen van Vuuren, featured in a DealMakers Magazine article titled "The role of mergers and acquisitions...

The role of mergers and acquisitions in the pharmaceutical industry
Healthcare & Pharmaceuticals

The role of mergers and acquisitions in the pharmaceutical industry

The pharmaceutical industry is dynamic – not just in current times but also historically. It is not surprising that the industry is one of the frontrunners in the market space when...

Is the SPAC back?
Corporate & Commercial Law

Is the SPAC back?

The use of SPACs, or special purpose acquisition companies, seems to be back. SPACs are shell companies with no existing business operations, that are established as an investment...

Reconsidering ordinary course of business covenants in M&A agreements during a pandemic

Reconsidering ordinary course of business covenants in M&A agreements during a pandemic

In concluding M&A transactions in such volatile times it is more imperative than ever that purchasers commencing new M&A transactions (which cater for an interim period between signing...

Disruptive technology and its impact on the M&A landscape
Corporate & Commercial Law

Disruptive technology and its impact on the M&A landscape

If a decade ago someone had told you that you’d be comfortable sharing your location with a stranger, hop into that stranger’s car and trust them to take you where you wanted to go, you would’ve...

From vision to fruition.